USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 5,688 Shares of Stock
USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 5,688 shares of the firm’s stock in a transaction dated Thursday, September 6th. The stock was sold at an average price of $124.27, for a total value of $706,847.76. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of USNA stock traded down $0.15 during mid-day trading on Friday, hitting $124.60. 4,386 shares of the stock were exchanged, compared to its average volume of 128,237. The firm has a market cap of $3.05 billion, a price-to-earnings ratio of 30.74 and a beta of 0.64. USANA Health Sciences, Inc. has a 12-month low of $55.50 and a 12-month high of $137.95.
USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, July 24th. The company reported $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.25. The company had revenue of $301.50 million for the quarter, compared to analyst estimates of $278.41 million. USANA Health Sciences had a return on equity of 29.50% and a net margin of 7.16%. The business’s quarterly revenue was up 17.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.98 earnings per share. research analysts forecast that USANA Health Sciences, Inc. will post 4.9 EPS for the current fiscal year.
Separately, Pivotal Research reaffirmed a “hold” rating and set a $135.00 price objective on shares of USANA Health Sciences in a report on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $135.00.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Further Reading: Marijuana Stocks Future Looks Bright
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.